WO2010046929A3 - Novel polymorphic forms of temazepam and processes for preparing the same - Google Patents
Novel polymorphic forms of temazepam and processes for preparing the same Download PDFInfo
- Publication number
- WO2010046929A3 WO2010046929A3 PCT/IN2009/000589 IN2009000589W WO2010046929A3 WO 2010046929 A3 WO2010046929 A3 WO 2010046929A3 IN 2009000589 W IN2009000589 W IN 2009000589W WO 2010046929 A3 WO2010046929 A3 WO 2010046929A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymorphic forms
- temazepam
- processes
- preparing
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Disclosed herein are novel crystalline polymorphic forms Form I, Form II, Form III, Form IV, Form V, Form VI, Form VII, Form VIII, Form IX, Form X and amorphous form of temazepam characterized by X-ray powder diffraction patterns, DSC, TGA and IR. In addition, the invention describes processes for the preparation of the various polymorphic forms.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2554CH2008 | 2008-10-17 | ||
| IN2554/CHE/2008 | 2008-10-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2010046929A2 WO2010046929A2 (en) | 2010-04-29 |
| WO2010046929A3 true WO2010046929A3 (en) | 2011-01-27 |
Family
ID=42119786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2009/000589 Ceased WO2010046929A2 (en) | 2008-10-17 | 2009-10-16 | Novel polymorphic forms of temazepam and processes for preparing the same |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2010046929A2 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3296249A (en) * | 1963-06-04 | 1967-01-03 | American Home Prod | 5-monocyclic aryl-1, 3-dihydro-2h-1, 4-benzodiazepin-2-ones |
| US4412952A (en) * | 1982-04-30 | 1983-11-01 | Sandoz, Inc. | Process for 3-hydroxy benzodiazepinones |
-
2009
- 2009-10-16 WO PCT/IN2009/000589 patent/WO2010046929A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3296249A (en) * | 1963-06-04 | 1967-01-03 | American Home Prod | 5-monocyclic aryl-1, 3-dihydro-2h-1, 4-benzodiazepin-2-ones |
| US4412952A (en) * | 1982-04-30 | 1983-11-01 | Sandoz, Inc. | Process for 3-hydroxy benzodiazepinones |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010046929A2 (en) | 2010-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008068625A3 (en) | Processes for preparing cinacalcet hydrochloride and polymorphic forms thereof | |
| WO2009002427A3 (en) | Methods of synthesizing cinacalcet and salts thereof | |
| NZ629684A (en) | Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one | |
| WO2009025873A3 (en) | Processes for the preparation of crystalline forms a, b and pure crystalline form a of erlotinib hcl | |
| IL220050A0 (en) | Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring | |
| EG25740A (en) | Process for the preparation of a treated mineral filler product, the obtained mineral filler productand its uses | |
| WO2008070072A3 (en) | Carvedilol forms, compositions, and methods of preparation thereof | |
| WO2008021342A3 (en) | Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone ) | |
| WO2009151899A3 (en) | Preparation of imatinib mesylate | |
| WO2011024192A3 (en) | Novel polymorphs of raltegravir | |
| IL195757A0 (en) | Processes for preparing intermediate compounds useful for the preparation of cinacalcet | |
| WO2009120746A3 (en) | Crystalline forms of sitagliptin phosphate | |
| WO2010070677A3 (en) | A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof | |
| WO2010008735A3 (en) | Solid states of o-desmethylvenlaf axine salts | |
| WO2012035544A3 (en) | A novel polymorphic form of rifaximin and process for its preparation | |
| WO2007098273A3 (en) | Novel crystalline forms of armodafinil and preparation thereof | |
| WO2009037538A3 (en) | Process for the preparation of lamivudine form i | |
| WO2007141593A3 (en) | Process for the preparation of metoprolol and its salts | |
| WO2010027848A3 (en) | Forms of lapatinib compounds and processes for the preparation thereof | |
| WO2009025792A3 (en) | Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof | |
| WO2008035360A3 (en) | Novel crystalline forms of candesartan cilexetil, candesartan, tritylated candesartan and tritylated candesartan cilexetil | |
| WO2008081041A3 (en) | Amorphous and crystalline forms of rivastigmine hydrogentartrate | |
| WO2009122429A3 (en) | Crystalline oxybutynin and process for preparing the same | |
| SI2225232T1 (en) | Process for the preparation of substituted 1,3-oxathiolanes | |
| WO2010046929A3 (en) | Novel polymorphic forms of temazepam and processes for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09821702 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 09821702 Country of ref document: EP Kind code of ref document: A2 |